Phase 3 Hyponatraemia Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Not Yet Recruiting
Phase 3
Tolvaptan versus Urea in acutely hospitalised patients with low blood sodium concentration
Hyponatraemia
University of Melbourne112 enrolled1 locationACTRN12624000756527
Completed
Phase 3
Tolvaptan versus fluid restriction in acutely hospitalised patients with low blood sodium concentration.
Hyponatraemia
The University of Melbourne52 enrolled1 locationACTRN12619001683123
Recruiting
Phase 3
A randomised controlled trial of Plasmalyte148 with 5% dextrose compared to 0.45% sodium chloride with 5% dextrose for maintenance intravenous fluid therapy in hospitalised children.
Prevention of iatrogenic hyponatraemia
Royal Children's Hospital690 enrolled1 locationACTRN12609000924257
Completed
Phase 3
Administration of 5% Dextrose/Hartmann's solution compared with 5% Dextrose/Half Normal (0.45%) Saline following spinal instrumentation surgery or craniotomy in children results in less post-operative hyponatraemia.
Post-operative hyponatraemia
Dr Mark Coulthard50 enrolled1 locationACTRN12607000116426